Volume 25, Number 10—October 2019
Dispatch
Genetic Characterization and Zoonotic Potential of Highly Pathogenic Avian Influenza Virus A(H5N6/H5N5), Germany, 2017–2018
Table
Group | Day postinfection, viral RNA load, genome copies/µL |
Seroconversion† | |||||
---|---|---|---|---|---|---|---|
0 | 1 | 3 | 5 | 7 | 9 | ||
Controls |
– |
– |
– |
– |
– |
– |
– |
H5N5 |
– | 0.2 | 0.2 | 0.1 | 100.6 | ND‡ | +/−§ |
– | 1.2 | 2.8 | 0.1 | – | – | + | |
– | 1.9 | 0.9 | 2.9 | – | – | + | |
– | 1.2 | – | 0.1 | – | – | + | |
– |
0.1 |
– |
8.2 |
0.9 |
– |
+ |
|
H5N6 | – | – | 0.8 | 1.3 | 1.3 | – | + |
– | 0.2 | 1.9 | 13.8 | 3.2 | – | + | |
– | 0.2 | – | 0.2 | 0.2 | – | + | |
– | – | – | – | – | – | + | |
– | 0 | 1.3 | 0.2 | 4.2 | – | + |
*ND, not done; –, negative.
†Seroconversion measured with sensitive nucleoprotein ELISA (ID Screen Influenza A Antibody Competition ELISA Kit; ID.Vet, https://www.id-vet.com) with day 14 or 7 serum sample, depending on day of animal sacrifice, and compared with preinoculation serum sample.
‡Sacrificed day 7 because animal displayed neurologic symptoms.
§Reaction interpreted as reactive but not positive.
1These authors contributed equally to this article.
Page created: September 17, 2019
Page updated: September 17, 2019
Page reviewed: September 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.